Not yet recruiting

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

By April 24, 2017 No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 116

Age Group: 18 Years to 90 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Participant, Care Provider, Investigator)|Primary Purpose: Treatment

Study ID Numbers: EORTC-08112

Study First Received: August 8, 2016

Last Updated: August 10, 2016

Estimated Primary Completion Date: February 2019

 

Primary Outcome Measures:

Progression-free survival|Overall survival|Overall Response Rate

Sponsors and Collaborators:

European Organisation for Research and Treatment of Cancer – EORTC

Website Link: https://ClinicalTrials.gov/show/NCT02863055

Leave a Reply

Call Now